Interpretation of Multi-disciplinary Consensus Statement Document Vaccinal Prevention in Adult Patients with Diabetes Mellitus

doi:10.12114/j.issn.1007-9572.2019.00.415

Abstract

Abstract: Diabetes is representatively one of the public health problems worldwide.The increasing morbidity and mortality due to chronic complications of diabetes has brought a huge burden to the society，national economy and public medical service.Although there are many guidelines for the management of diabetes，there is no consensus or guidelines for multiple vaccinations for adults with diabetes.In 2018 Italian Society of Hygiene，Preventive Medicine and Public Health，Italian Association of Medical Diabetologists，Italian Federation of General Practitioners，Italian Society of Diabetology and Italian Society of General Medicine & Primary Care jointly issued a multi-disciplinary consensus statement on vaccinations for adult diabetics——Multi-disciplinary Consensus Statement Document Vaccinal Prevention in Adult Patients with Diabetes Mellitus.This consensus statement describes the mechanism of predisposition to infection in adults with diabetes，as well as the significance and frequency of flu vaccination，pneumococcal vaccination，anti-herpes zoster vaccination，meningococcal vaccination，and anti-diphteria-tetanus-pertussis vaccination.It highlights the important role of diabetes-treating physicians and general practitioners in supervising adults with diabetes for vaccination.There are still no corresponding clinical guidelines or consensus in China up to now，but due to the increasing number of patients with diabetes and the heavy burden of health economics，here this paper tries to interpret this consensus statement issued by Italy to provide references for the formulation of vaccination policy and clinical management for infectious diseases of adult diabetics in China.

Key words: Diabetes, Adult, Vaccination, Consensus, Statement, Guideline

摘要： 糖尿病是世界范围内的公共卫生问题之一，糖尿病慢性并发症所导致的发病率和死亡率增加，已经给社会、经济和医疗带来了巨大的负担。虽然有关糖尿病管理方面有许多指南出台，但对于成人糖尿病患者多种疫苗的预防接种，既往还没有共识/指南全面提及过。2018年意大利卫生、预防医学和公共卫生协会联合意大利医学糖尿病专家协会、意大利全科医生联合会、意大利糖尿病学会、意大利全科医学社团和初级保健学会共同发表了成人糖尿病患者的预防接种的多学科共识声明，即《2018多学科共识声明：成人糖尿病患者的预防接种》。这篇共识声明阐述了成人糖尿病患者易患感染的机制，以及流感疫苗、肺炎球菌疫苗、带状疱疹病毒疫苗、脑膜炎球菌疫苗、百日咳-白喉-破伤风疫苗等疫苗接种的意义和接种频率，并强调了糖尿病医师及全科医师在督导成人糖尿病患者进行疫苗接种中的重要作用。我国尚缺乏相应的临床指南或共识，但由于糖尿病患者越来越多，带来的卫生经济学负担越来越重，本文就意大利发表的这篇共识声明要点进行解读，旨在为我国成人糖尿病感染性疾病的预防接种政策制定及临床工作提供参考。

关键词: 糖尿病, 成年人, 预防接种, 共识, 声明, 指南

LI Xu,ZHANG Ziqiang. Interpretation of Multi-disciplinary Consensus Statement Document Vaccinal Prevention in Adult Patients with Diabetes Mellitus　[J]. Chinese General Practice, 2019, 22(36): 4420-4423. DOI: 10.12114/j.issn.1007-9572.2019.00.415.
李旭,张子强. 《2018多学科共识声明：成人糖尿病患者的预防接种》解读[J]. 中国全科医学, 2019, 22(36): 4420-4423. DOI: 10.12114/j.issn.1007-9572.2019.00.415.

References

［1］ICARDI G，FRANCIA F，DI BARTOLO P，et al．Multi-disciplinary Consensus Statement Document Vaccinal Prevention in Adult Patients with Diabetes Mellitus［J］．J Prev Med Hyg，2018，59（4）：e249-256．DOI：10.15167/2421-4248/jpmh2018.59.4.1124.
［2］LóPEZ-SIMARRO F，REDONDO MARGüELLO E，MEDIAVILLA BRAVO J J，et al．Prevention and treatment of infectious diseases in diabetic patients［J］．Semergen，2019，45（2）：117-127．DOI：10.1016/j.semerg.2018.07.007.
［3］GENEEV C，MATHEW N，JACOB J J.Vaccination status，knowledge，and acceptance of adult vaccinations against respiratory illness among patients with type 2 diabetes mellitus［J］．Indian J Endocrinol Metab，2018，22（2）：280-282．DOI：10.4103/ijem.IJEM_29_18.
［4］CASEY J I，HEETER B J，KLYSHEVICH K A.Impaired response of lymphocytes of diabetic subjects to antigen of staphylococcus aureus［J］．J Infect Dis，1977，136（4）：495-501．DOI：10.1093/infdis/136.4.495.
［5］GRIGOR'EVA L P，BREEVA L G，MAKHNACH L D.Dynamics of various indicators of natural immunity in diabetes mellitus［J］．Probl Endokrinol（Mosk），1979，25（5）：13-17.
［6］ALBA-LOUREIRO T C，MUNHOZ C D，MARTINS J O，et al．Neutrophil function and metabolism in individuals with diabetes mellitus［J］．Braz J Med Biol Res，2007，40（8）：1037-1044．DOI：10.1590/s0100-879x2006005000143.
［7］ATLI T，KEVEN K，AVCI A，et al．Oxidative stress and antioxidant status in elderly diabetes mellitus and glucose intolerance patients［J］．Arch Gerontol Geriatr，2004，39（3）：269-275．DOI：10.1016/j.archger.2004.04.065.
［8］ONORATI F，RUBINO A S，CUDA A，et al．Impact of endothelial activation on infective and inflammatory complications after cardiac surgery in type Ⅱ diabetes mellitus［J］．Int J Artif Organs，2011，34（6）：469-480．DOI：10.5301/IJAO.2011.8329.
［9］MAD'AR R，BENESOVá D，BRANDEJSKá D，et al．Vaccination of patients with diabetes mellitus——a retrospective study［J］．Cent Eur J Public Health，2011，19（2）：98-101.
［10］MACLNTYRE C R，MAHIMBO A，MOA A M，et al．Influenza vaccine as a coronary intervention for prevention of myocardial infarction［J］．Heart，2016，102（24）：1953-1956．DOI：10.1136/heartjnl-2016-309983.
［11］JAMALI A，SABAHI F，BAMDAD T，et al．A DNA vaccine-encoded nucleoprotein of influenza virus fails to induce cellular immune responses in a diabetic mouse model［J］．Clin Vaccine Immunol，2010，17（4）：683-687．DOI：10.1128/CVI.00445-09.
［12］SEO Y B，BAEK J H，LEE J，et al．Long-term immunogenicity and safety of a conventional influenza vaccine in patients with type 2 diabetes［J］．Clin Vaccine Immunol，2015，22（11）：1160-1165．DOI：10.1128/CVI.00288-15.
［13］WANG I K，LIN C L，CHANG Y C，et al．Effectiveness of influenza vaccination in elderly diabetic patients：a retrospective cohort study［J］．Vaccine，2013，31（4）：718-724．DOI：10.1016/j.vaccine.2012.11.017.
［14］REMSCHMIDT C，WICHMANN O，HARDER T.Vaccines for the prevention of seasonal influenza in patients with diabetes：systematic review and meta-analysis［J］．BMC Med，2015，13：53．DOI：10.1186/s12916-015-0295-6.
［15］CASANOVA L，GOBIN N，VILLANI P，et al．Bias in the measure of the effectiveness of seasonal influenza vaccination among diabetics［J］．Prim Care Diabetes，2016，10（6）：398-406．DOI：10.1016/j.pcd.2016.05.005.
［16］TAN E K，LIM L H，TEOH Y L，et al．Influenza and seasonal influenza vaccination among diabetics in Singapore：knowledge，attitudes and practices［J］．Singapore Med J，2010，51（8）：623-630.
［17］YE L X，CHEN J P，FANG T，et al．Determinants of healthcare workers' willingness to recommend the seasonal influenza vaccine to diabetic patients：a cross-sectional survey in Ningbo，China［J］．Hum Vaccin Immunother，2018：1-8．DOI：10.1080/21645515.2018.1496767.
［18］SEMINOG O O，GOLDACRE M J.Risk of pneumonia and pneumococcal disease in people hospitalized with diabetes mellitus：English record-linkage studies［J］．Diabet Med，2013，30（12）：1412-1419．DOI：10.1111/dme.12260.
［19］PAPAGIANNI M，METALLIDIS S，TZIOMALOS K.Herpes zoster and diabetes mellitus：a review［J］．Diabetes Ther，2018，9（2）：545-550．DOI：10.1007/s13300-018-0394-4.

[1]	BAI Jiaxin, CHEN Yu, ZHOU Yiheng, LIU Lidi, YANG Rong, YAO Yi, YUAN Bo, ZHANG Yonggang, LEI Yi, ZENG Rui, JIA Yu, LIAO Xiaoyang. Assessment and Treatment of Early-onset Hypertension: Position Statement of the British and Irish Hypertension Association and Its Implications for Clinical Management of Early-onset Hypertension in China [J]. Chinese General Practice, 2025, 28(30): 3741-3746.
[2]	LI Ling, LI Yaping, QIAN Shixing, NIE Jing, LU Chunhua, LI Xia. Research on Influencing Factors and Risk Prediction of Cognitive Function in Community-dwelling Middle-aged and Elderly People [J]. Chinese General Practice, 2025, 28(30): 3773-3778.
[3]	LU Donglei, YANG Fengying, FENG Zhanpeng, CAO Liquan, TAN Sijie. Conccurent Training Can Improve the Physical Health in Diabesity Individuals: a Meta-analysis [J]. Chinese General Practice, 2025, 28(27): 3410-3421.
[4]	ZHANG Yunuo, LI Ruibin, WANG Wei. Correlation Analysis of Serum Nesfatin-1 and Ghrelin Levels with Glycolipid Metabolism and Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(26): 3264-3270.
[5]	ZHANG Ruimin, DONG Zheyi, LI Shuang, WANG Qian, CHEN Xiangmei. Traditional Chinese Medicine Factors Associated with Diabetic Nephropathy Diagnosed by Renal Biopsy [J]. Chinese General Practice, 2025, 28(26): 3307-3313.
[6]	CUI Yuyang, CHENG Guirong, ZENG Yan, HUANG Zhaolan, TAN Wei. Association between Marital Status, Social Support and Lifestyle with Cognitive Impairment among Community-dwelling Older Adults: Based on the Baseline Survey of Hubei Memory and Aging Cohort Study [J]. Chinese General Practice, 2025, 28(26): 3240-3247.
[7]	TANG Shangfeng, HUANG Yangzhen, ZHENG Yanxi, PAN Yangyang, XIONG Zhongbao, QING Hua, SONG Jia, WEI Yilin, DONG Heng, WANG Chunying, CHEN Manwei, ZHANG Kangkang. Specification for the Integration of Healthcare and Prevention Services in Diabetes at the Primary Level [J]. Chinese General Practice, 2025, 28(25): 3096-3103.
[8]	YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058.
[9]	WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening. Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention [J]. Chinese General Practice, 2025, 28(24): 2985-2992.
[10]	National Clinical Research Center for Infectious Diseases Jiangxi Branch, Jiangxi Provincial Key Laboratory of Tuberculosis. Expert Consensus on the Treatment of Pulmonary Tuberculosis Complicated with Chronic Hepatitis B Virus Infection [J]. Chinese General Practice, 2025, 28(24): 2961-2967.
[11]	LIU Yueying, WANG Xueli, LIU Yuqiu, WEI Limin. Correlation of Fasting C-peptide to Diabetes Duration Ration and Type 2 Diabetes Mellitus Combined with Metabolism-related Fatty Liver Disease [J]. Chinese General Practice, 2025, 28(23): 2852-2860.
[12]	WANG Peng, QIU Lixia, XU Shanshan, ZHANG Yang, ZHANG Jing, DU Xiaofei. Advances in the Co-management of Metabolism Dysfunction-associated Fatty Liver Disease and Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(23): 2846-2851.
[13]	BAI Xue, CHEN Qianqian, LI Jie. Innovative Practices in Chronic Disease Management: a New Model for Generalist-Specialist Combination Management of Diabetes and Metabolic Dysfunction-associated Fatty Liver Disease [J]. Chinese General Practice, 2025, 28(23): 2841-2845.
[14]	Chinese Hospital Association, Committee for Healthcare Simulation. Expert Consensus on the Application Technology System Standard of Virtual Simulation for Clinical Practice Skills [J]. Chinese General Practice, 2025, 28(23): 2833-2840.
[15]	CHEN Linfeng, WANG Chenxia, HE Jinpeng. Impact of Regular Outpatient Follow-up and Off-site App Engagement on Metabolic Indicators in Type 2 Diabetes Mellitus Patients under the Shared Care Model [J]. Chinese General Practice, 2025, 28(22): 2762-2768.